Oncology Nurse Advisor
Recent research bolsters the case that radiotherapy to treat primary endometrial cancer is associated with an increased risk of second primary malignancies (SPMs), highlighting the need for ...
Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
Feb 28, 2018 · A patient in Germany undergoes proton therapy. At $225 million per system, the precision of proton beam radiotherapy is not necessarily overshadowing its high costs.
Managing TSH Levels After Total Thyroidectomy
Sep 8, 2015 · How should thyroid-stimulating hormone (TSH) be managed so its levels can be maintained within the normal range after total thyroidectomy for cancer of the papillary thyroid?
Cancer and Fibromyalgia: Addressing the Needs of Patients …
A patient experiences fibromyalgia. In addition to being common yet serious diseases, both cancer and fibromyalgia bring a high burden of physical pain and negative effects on mental health.
PRD Monitoring May Be Suitable Replacement for MRD in …
Dec 2, 2024 · Analysis showed that a positive PRD evaluation by NGF (11.5% of patients) was linked with a 13-fold increase in the risk of disease progression or death (median PFS and OS, 2.5 and 47 months ...
Talquetamab Plus Teclistamab Shows Promise in Multiple Myeloma
5 days ago · HealthDay News — For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage of patients and a higher incidence of grade 3 or 4 ...
Tumor Markers (Fact Sheet) - Oncology Nurse Advisor
Apr 4, 2016 · What are tumor markers? Tumor markers are substances that are produced by cancer or by other cells of the body in response to cancer or certain benign (noncancerous) conditions.
Function of a micron filter - Oncology Nurse Advisor
Why do some drugs need a micron filter? What is it filtering out? What harm could be caused by not using a filter? —P. Manfresca, BSN. Filters for intravenous (IV) medication administration are ...
Adjuvant Nivolumab Improves Outcomes in High-Risk MIUC
Dec 18, 2024 · References: Galsky MD, Witjes JA, Gschwend JE, et al. Adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma: Expanded efficacy from CheckMate 274. J Clin Oncol.Published online ...
Drug sequence with gemcitabine - Oncology Nurse Advisor
Mar 23, 2015 · When giving gemcitabine (Gemzar) and cisplatin (Platinol), is it better to give gemcitabine first to reduce myelosuppression with every indication?